These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8639737)

  • 1. Epidemiology of breast cancer: the Nordic contribution.
    Ewertz M
    Eur J Surg; 1996 Feb; 162(2):97-9. PubMed ID: 8639737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoidable cancers in the Nordic countries. Exogenous hormones.
    Winther JF; Dreyer L; Tryggvadottir L
    APMIS Suppl; 1997; 76():132-40. PubMed ID: 9462825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal replacement therapy and breast cancer].
    Noël G; Feuvret L; Gasowski M; Bernard A; Cappelaere P
    Bull Cancer; 1998 Dec; 85(12):997-1014. PubMed ID: 9917553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of cancer of the breast].
    Ferrero JM; Namer M
    Arch Anat Cytol Pathol; 1994; 42(5):198-205. PubMed ID: 7872810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005.
    Hemminki E; Kyyrönen P; Pukkala E
    Maturitas; 2008 Dec; 61(4):299-304. PubMed ID: 18996655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
    Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for in situ breast cancer.
    Longnecker MP; Bernstein L; Paganini-Hill A; Enger SM; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):961-5. PubMed ID: 8959317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormones and breast cancer.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
    Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
    Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological risk factors for breast cancer--a review.
    Okobia MN; Bunker CH
    Niger J Clin Pract; 2005 Jun; 8(1):35-42. PubMed ID: 16392454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based cohort study of HRT use and breast cancer in southern Sweden.
    Olsson H; Bladström A; Ingvar C; Möller TR
    Br J Cancer; 2001 Sep; 85(5):674-7. PubMed ID: 11531250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.